Similar articles

• Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation-predominant irritable bowel syndrome.

  Tack J, Middleton SJ, Horne MC, Piessevaux H, Bloor JS, Meyers NL, Palmer RM. Tack J, et al. Aliment Pharmacol Ther. 2006 Jun 1;23(11):1655-65. doi: 10.1111/j.1365-2036.2006.02940.x. Aliment Pharmacol Ther. 2006. PMID: 16696817 Clinical Trial.
• Clinical trial: renzapride therapy for constipation-predominant irritable bowel syndrome--multicentre, randomized, placebo-controlled, double-blind study in primary healthcare setting.

  George AM, Meyers NL, Hickling RI. George AM, et al. Aliment Pharmacol Ther. 2008 May;27(9):830-7. doi: 10.1111/j.1365-2036.2008.03649.x. Epub 2008 Feb 14. Aliment Pharmacol Ther. 2008. PMID: 18284648 Clinical Trial.
• Identification of patients with non-d, non-C irritable bowel syndrome and treatment with renzapride: an exploratory, multicenter, randomized, double-blind, placebo-controlled clinical trial.

  Spiller RC, Meyers NL, Hickling RI. Spiller RC, et al. Dig Dis Sci. 2008 Dec;53(12):3191-200. doi: 10.1007/s10620-008-0295-x. Epub 2008 May 10. Dig Dis Sci. 2008. PMID: 18465239 Clinical Trial.
• Renzapride: a new drug for the treatment of constipation in the irritable bowel syndrome.

  Scarpellini E, Tack J. Scarpellini E, et al. Expert Opin Investig Drugs. 2008 Nov;17(11):1663-70. doi: 10.1517/13543784.17.11.1663. Expert Opin Investig Drugs. 2008. PMID: 18922103 Review.
• Clinical trials in irritable bowel syndrome: a review.

  Ervin CM, Mangel AW. Ervin CM, et al. Rev Recent Clin Trials. 2013 Mar;8(1):9-22. doi: 10.2174/1574887111308010003. Rev Recent Clin Trials. 2013. PMID: 23130604 Review.